Abstract
Neural stem/progenitor cells (NSPCs) have the potential to differentiate into neurons, astrocytes, and/or oligodendrocytes. Because these cells can be expanded in culture, they represent a vast source of neural cells. With the recent discovery that patient fibroblasts can be reprogrammed directly into induced NSPCs, the regulation of NSPC fate and function, in the context of cell-based disease models and patient-specific cell-replacement therapies, warrants review.
Original language | English |
---|---|
Pages (from-to) | 701-715 |
Number of pages | 15 |
Journal | Wiley Interdisciplinary Reviews: Systems Biology and Medicine |
Volume | 5 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2013 |